| Characteristics | All (N = 44) | LMS (N = 22) | ESS (N = 22) |
|---|
| No. (%) | No. (%) | No. (%) |
|---|
| Age (years) |
| Mean ± SD | 56.84 ±7.93 | 62.50 ±4.94 | 51.18 ±6.10 |
| Median (Range) | 57 (39-72) | 62 (56-72) | 50 (39-65) |
| ≤ 55 years | 18 (40.9%) | 0 (0%) | 18 (81.8%) |
| > 55 years | 26 (59.1%) | 22 (100%) | 4 (18.2%) |
| Size |
| <5 cm | 6 (13.6%) | 4 (18.2%) | 2 (9.1%) |
| >5 cm | 38 (86.4%) | 18 (81.8%) | 20 (90.9%) |
| Grade |
| Grade I | 9 (20.5%) | 5 (22.7%) | 4 (18.2%) |
| Grade II | 12 (27.3%) | 7 (31.8%) | 5 (22.7%) |
| Grade III | 23 (52.3%) | 10 (45.5%) | 13 (59.1%) |
| Extrauterine extension |
| Absent | 6 (13.6%) | 4 (18.2%) | 2 (9.1%) |
| Present | 9 (20.5%) | 5 (22.7%) | 4 (18.2%) |
| N/A | 29 (65.9%) | 13 (59.1%) | 16 (72.7%) |
| LVSI |
| Absent | 21 (47.7%) | 14 (63.6%) | 7 (31.8%) |
| Present | 23 (52.3%) | 8 (36.4%) | 15 (68.2%) |
| Bladder/Rectum extension |
| Absent | 33 (75%) | 18 (81.8%) | 15 (68.2%) |
| Present | 10 (22.7%) | 4 (18.2%) | 6 (27.3%) |
| N/A | 1 (2.3%) | 0 (0%) | 1 (4.5%) |
| Other pelvic organ invasion |
| Absent | 15 (34.1%) | 8 (36.4%) | 7 (31.8%) |
| Present | 29 (65.9%) | 14 (63.6%) | 15 (68.2%) |
| Adnexal invasion |
| Absent | 11 (25%) | 7 (31.8%) | 4 (18.2%) |
| Present | 33 (75%) | 15 (68.2%) | 18 (81.8%) |
| Lymph node |
| Negative | 16 (36.4%) | 10 (45.5%) | 6 (27.3%) |
| Positive | 28 (63.6%) | 12 (54.5%) | 16 (72.7%) |
| Distant metastasis |
| Absent | 29 (65.9%) | 18 (81.8%) | 11 (50%) |
| Present | 15 (34.1%) | 4 (18.2%) | 11 (50%) |
